Effect of antidepressive therapy on retinal contrast processing in depressive disorder.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 22700080.
- Also identified by DOI 10.1192/bjp.bp.111.100560.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently, we reported a reduced retinal contrast gain in unmedicated and medicated patients with major depression. To analyse whether the contrast gain normalises after successful antidepressive therapy by recording the pattern electroretinogram (PERG) in healthy controls and patients with depression before and after antidepressive therapy. Fourteen patients diagnosed with major depression were repeatedly scanned and the results compared with that from 40 matched controls. The retinal contrast gain was lower at baseline in patients with depression, was normalised with remission and correlated with the severity of depression. Patients who did not achieve remission retained significantly lower contrast gain at follow-up. The study provides evidence for a state-dependent modulation of retinal contrast gain in patients with major depression. Reduced contrast gain normalised after therapy. A PERG-based contrast gain could serve as a state marker of depression.
Medical subject headings
- Antidepressive Agents
- Contrast Sensitivity
- Major Depressive Disorder
- Vision Disorders